Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gαs/Gβγ protein-protein interface is the structural junction between the alpha-s subunit (Gαs) and the beta-gamma (Gβγ) dimer within the heterotrimeric Gs protein complex. This interface is central to the canonical G protein signaling cycle, where GPCR activation triggers the exchange of GDP for GTP on Gαs, leading to the dissociation of the heterotrimer into Gαs-GTP and Gβγ subunits (UniProt P63092). The liberated Gαs-GTP then activates adenylate cyclase, increasing intracellular cAMP, while Gβγ can independently modulate various effectors like ion channels and kinases (StatPearls: G Protein-Coupled Receptors). Mutations in the Gαs subunit, such as those found in McCune-Albright syndrome or certain cancers, can lead to constitutive activation of this pathway (NIH/GARD). Therapeutic targeting of the Gαs/Gβγ interface aims to use small molecules or peptides to either stabilize the inactive heterotrimer or prevent the re-association/dissociation process, thereby modulating downstream signaling more selectively than broad GPCR ligands (PubMed: 16627734). While promising for treating G protein-related pathologies, the ubiquitous nature of Gs signaling poses significant risks for systemic toxicity and off-target effects.
Stabilization of the inactive heterotrimeric G protein complex or competitive inhibition of subunit dissociation to prevent effector activation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine nucleotide-binding protein G(s) subunit alpha and G protein subunit beta-gamma interface (Gαs/Gβγ interface).